CA2024694A1 - Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors - Google Patents
Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitorsInfo
- Publication number
- CA2024694A1 CA2024694A1 CA2024694A CA2024694A CA2024694A1 CA 2024694 A1 CA2024694 A1 CA 2024694A1 CA 2024694 A CA2024694 A CA 2024694A CA 2024694 A CA2024694 A CA 2024694A CA 2024694 A1 CA2024694 A1 CA 2024694A1
- Authority
- CA
- Canada
- Prior art keywords
- bisphosphonic acids
- bone resorption
- acyloxymethyl esters
- resorption inhibitors
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4075—Esters with hydroxyalkyl compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Abstract
The invention relates to acyloxymethyl esters of bisphosphonic acids, halo-bisphosphonic acids and hydroxy-bisphosphonic acids which exhibit oral bioavailability and are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40341189A | 1989-09-06 | 1989-09-06 | |
US403,411 | 1989-09-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2024694A1 true CA2024694A1 (en) | 1991-03-07 |
CA2024694C CA2024694C (en) | 2000-10-17 |
Family
ID=23595658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002024694A Expired - Fee Related CA2024694C (en) | 1989-09-06 | 1990-09-05 | Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0416689B1 (en) |
JP (1) | JPH07119230B2 (en) |
CA (1) | CA2024694C (en) |
DE (1) | DE69023844T2 (en) |
LV (1) | LV11473B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2114946T3 (en) * | 1991-09-05 | 1998-06-16 | Toray Industries | DERIVATIVE OF METHANODIPHOSPHONIC ACID, ITS PRODUCTION AND MEDICINAL USE. |
US5283057A (en) * | 1992-04-24 | 1994-02-01 | The Procter & Gamble Company | Risedronate in oral compositions |
HUT69699A (en) * | 1992-05-29 | 1995-09-28 | Procter & Gamble Pharma | Sulfur-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism |
NZ272608A (en) | 1994-07-22 | 2000-05-26 | Lilly Co Eli | Inhibiting bone loss by administering a bisphosphonate and a second compound selected from various compounds, including 2-phenyl-3-aroylbenzothienes; bisphosphonate combination salts |
SE9703691D0 (en) * | 1997-10-10 | 1997-10-10 | Astra Ab | Pharmaceutical compositions |
FI104901B (en) * | 1997-10-20 | 2000-04-28 | Leiras Oy | New methylene bisphosphonic acid derivatives |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
FR2837490B1 (en) * | 2002-03-21 | 2009-04-17 | Univ Paris 13 | NOVEL DERIVATIVES OF BISPHOSPHONATES, THEIR PREPARATIONS AND USES |
CA2451881A1 (en) * | 2001-07-16 | 2003-01-30 | Universite Paris 13 | Novel bisphosphonate derivatives, their preparation methods and uses |
US6927036B2 (en) | 2002-02-19 | 2005-08-09 | Xero Port, Inc. | Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
US7662987B2 (en) | 2003-07-15 | 2010-02-16 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl compounds |
KR101140559B1 (en) | 2003-08-20 | 2012-07-05 | 제노포트 인코포레이티드 | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
EP1716115B1 (en) | 2003-12-30 | 2013-02-27 | XenoPort, Inc. | Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof |
JP4938771B2 (en) | 2005-06-20 | 2012-05-23 | ゼノポート,インコーポレーテッド | Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis, and uses |
US7531572B2 (en) | 2006-07-28 | 2009-05-12 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs of α-amino acids, methods of synthesis and use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2534391C2 (en) * | 1975-08-01 | 1983-01-13 | Henkel KGaA, 4000 Düsseldorf | 1-Hydroxy-3-aminoalkane-1,1-diphosphonic acids |
DE2745083C2 (en) * | 1977-10-07 | 1985-05-02 | Henkel KGaA, 4000 Düsseldorf | Hydroxydiphosphonic acids and processes for their preparation |
FR2531088B1 (en) * | 1982-07-29 | 1987-08-28 | Sanofi Sa | ANTI-INFLAMMATORY PRODUCTS DERIVED FROM METHYLENEDIPHOSPHONIC ACID AND THEIR PREPARATION METHOD |
GB8419489D0 (en) * | 1984-07-31 | 1984-09-05 | Leo Pharm Prod Ltd | Chemical compounds |
GB8530603D0 (en) * | 1985-12-12 | 1986-01-22 | Leo Pharm Prod Ltd | Chemical compounds |
DE3623397A1 (en) * | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | NEW DIPHOSPHONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
-
1990
- 1990-08-29 DE DE69023844T patent/DE69023844T2/en not_active Expired - Fee Related
- 1990-08-29 EP EP90202312A patent/EP0416689B1/en not_active Expired - Lifetime
- 1990-09-05 CA CA002024694A patent/CA2024694C/en not_active Expired - Fee Related
- 1990-09-06 JP JP2234649A patent/JPH07119230B2/en not_active Expired - Fee Related
-
1996
- 1996-02-06 LV LVP-96-33A patent/LV11473B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0416689A3 (en) | 1991-06-26 |
LV11473A (en) | 1996-08-20 |
LV11473B (en) | 1996-12-20 |
JPH03106893A (en) | 1991-05-07 |
JPH07119230B2 (en) | 1995-12-20 |
DE69023844T2 (en) | 1996-06-20 |
EP0416689B1 (en) | 1995-11-29 |
DE69023844D1 (en) | 1996-01-11 |
CA2024694C (en) | 2000-10-17 |
EP0416689A2 (en) | 1991-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2149052A1 (en) | Dry mix formulation for bisphosphonic acids | |
CA2024694A1 (en) | Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors | |
CA2188567A1 (en) | Wet granulation formulation for bisphosphonic acids | |
PT1914237E (en) | Phosphonate ester antiviral compounds | |
PT939748E (en) | Gypsum-boards having increased resistance to permanent deformation | |
CA2018477A1 (en) | Process for preparing 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic, acid monosodium salt trihydrate | |
AU1876788A (en) | Methylene phosphonoalkylphosphinates, pharmaceutical compositions , and methods for treating abnormal calcium and phosphate metabolism | |
CA2035179A1 (en) | Pharmaceutical compositions containing insoluble salts of bisphosphonic acids | |
EP0341961A3 (en) | Polymalonic acids as boneaffinity agents | |
HUP9802219A3 (en) | Processes for the preparation of n-phosphonomethylglycine from n-phosphonomethyliminodiacetic acid | |
GB8902740D0 (en) | Process for the preparation of triaryl phosphate | |
HU901602D0 (en) | Continuous process for the production of solid calcium phosphates from raw phosphate without the addition of phosphoric acid and lime | |
LTIP1742A (en) | Process for the preparation of phosphoric or thiophosphoric acid ethylenimides | |
EP0417558A3 (en) | S-haloalkyl(di)(tri)(thio)phosphoric(phosphonic)acid(amide) esters | |
EP0723968A3 (en) | Process for the preparation of thiophosphoric acid 0,0'-diesters and their salts as well as their preparation | |
CA2192456A1 (en) | Pyridylbisphosphonates for use as a therapeutical agent | |
HUP0004653A3 (en) | The use of bisphosphonates for producing medicaments use ful for inhibiting bone resorption | |
FR2620118B1 (en) | PROCESS FOR THE MANUFACTURE OF PHOSPHATE FERTILIZERS AND PRODUCTS OBTAINED | |
IE873052L (en) | Calcium phosphate scale inhibition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |